Oric Pharmaceuticals, Inc. 8-K

What Happened
Oric Pharmaceuticals, Inc. announced its financial results for the fourth quarter and full year ended December 31, 2025 in a press release issued on February 23, 2026. The company furnished the press release as Exhibit 99.1 to Form 8-K (Item 2.02), which is incorporated by reference into the filing.

Key Details

• Filing date: February 23, 2026 (Form 8-K, Item 2.02).
• Reporting period: quarter and fiscal year ended December 31, 2025.
• Press release attached as Exhibit 99.1 and incorporated by reference.
• The filing states the press release is being furnished and, per Item 9.01, is not deemed “filed” for purposes of Section 18 of the Exchange Act nor automatically incorporated by reference into other securities filings.

Why It Matters
This 8-K informs investors that Oric has publicly released its quarterly and annual financial results; investors should review the attached press release for specifics on revenue, expenses, cash position, and management commentary. Because the exhibit is furnished (not “filed”), investors should also watch for company quarterly/annual reports (10-Q/10-K) for audited figures and more detailed disclosures that will carry the fuller legal filing status.